Aberrant cytokeratin expression and high susceptibility to apoptosis in autoimmune hepatitis

Hepatology Research

Volumn 25, Issue 3, 2003, Pages 271-280

  Murota, Masayuki ^a   Watanabe, Seishiro ^a   Fujita, Jiro ^a   Ohtsuki, Yuji ^b   Wu, Fei ^a   Yoshida, Shunhei ^a   Kita, Yuko ^a   Funakoshi, Fumi ^a   Masaki, Tsutomu ^a   Kurokohchi, Kazutaka ^a   Uchida, Naohito ^a   Ishida, Toshihiko ^a   Kuriyama, Shigeki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; B cell leukemia 2; Bax; Caspase; Cytokeratin; HLA DR; Immunohistochemistry

Indexed keywords

CASPASE 3; CATHEPSIN D; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN 8; HLA DR ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; CELL DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE ACTIVITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOSURVEILLANCE; LIVER CELL; LIVER PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037734210     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00277-2     Document Type: Article

References (33)

1. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
2. Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995;40:435-56.
3. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996;334:897-903.
4. Bartek J, Bartkova J, Taylor-Papadimitriou J, et al. Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J 1986;18:565-75.
5. Kasper M, Stosiek P, Typlt H, Karsten U. Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur J Cancer Clin Oncol 1987;23:137-47.
6. Osborn M, Van Lessen G, Weber K, Kloppel G, Altmannsberger M. Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest 1986;55:497-504.
7. Ramaekers F, Huysmans A, Schaart G, Moesker O, Vooijs P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987;170:235-49.
8. Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver diseases: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology 1989;15:125-35.
9. Lee JS. Regulation of HLA class II gene expression. In: Albert ED, editor. Immunobiology of HLA, vol. 2. New York: Springer, 1989:49-63.
10. Schwartz BD. HLA molecules: sentinels of the immune response. Am J Respir Cell Mol Biol 1991;5:211-2.
11. Puri J, Taplits M, Alava M, Bonvini E, Hoffman T. Inhibition of release of arachidonic acid, superoxide, and IL-1 from human monocytes by monoclonal anti-HLA class II antibodies: effects at proximal and distal points of inositol phospholipid hydrolysis pathway. Inflammation 1992;16:31-44.
12. Prasad S, Soldatenkov VA, Srinivasarao G, Dritschilo A. Identification of keratins 18, 19 and heat-shock protein 90β as candidate substrates of proteolysis during ionizing radiation-induced apoptosis of estrogen-receptor negative breast tumor cells. Int J Oncol 1998;13:757-64.
13. Ichida F, Tsuji T, Omata M, et al. New Inuyama Classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112-9.
14. Goldstein NS, Soman A, Gordon SC. Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis. Am J Clin Pathol 2001;116:846-53.
15. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation". Hepatology 1992;16:1069-83.
16. Gerber MA, Thung SN, Shen S, Stromeyer FW, Ishak KG. Phenotypic characterization of hepatic proliferation. Antigen expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol 1983;110:70-4.
17. Uchida T, Peters RL. The nature and origin of proliferated bile ductules in alcoholic liver disease. Am J Clin Pathol 1983;79:326-33.
18. Desmet V, Roskams T, van Eyken P. Ductular reaction in the liver. Pathol Res Pract 1995;191:513-24.
19. James J, Lygidakis NJ, van Eyken P, et al. Application of keratin immunocytochemistry and sirius red staining in evaluating intrahepatic changes with acute extrahepatic cholestasis due to hepatic duct carcinoma. Hepatogastroenterol 1989;36:151-5.
20. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990;99:466-77.
21. Murota M, Nishioka M, Fujita J, et al. Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis. Clin Exp Immunol 2001;125:291-9.
22. Fukusato T, Gerber MA, Thung SN, Ferrone S, Schaffner F. Expression of HLA class 1 antigens on hepatocytes in liver disease. Am J Pathol 1986;123:264-70.
23. Nagafuchi Y, Hobbs KE, Thomas HC, Scheuer PJ. Expression of beta-2-microglobulin on hepatocytes after liver transplantation. Lancet 1985;1(8428):551-4.
24. Nagafuchi Y, Scheuer PJ. Expression of β2-microglobulin on hepatocytes in acute and chronic type B hepatitis. Hepatology 1986;6:20-3.
25. van Den Oord JJ, de Vos R, Desmet VJ. In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology 1986;6:981-9.
26. Hagihara M, Hosoi K, Kagawa T, et al. Serum soluble HLA-DR antigens in autoimmune hepatitis. Autoimmunity 1999;31:85-93.
27. Paterson AC, Sciot R, Kew MC, Callea F, Dusheiko GM, Desmet VJ. HLA expression in human hepatocellular carcinoma. Br J Cancer 1988;57:369-73.
28. Fox CK, Furtwaengler A, Nepomuceno RR, Martinez OM, Krams SM. Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver 2001;21:272-9.
29. Caulin C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997;138:1379-94.
30. Tinnemans MM, Lenders MH, ten Velde GP, Ramaekers FC, Schutte B. Alterations in cytoskeletal and nuclear matrix-associated proteins during apoptosis. Eur J Cell Biol 1995;68:35-46.
31. Ku NO, Liao J, Omary MB. Apoptosis generates stable fragments of human type I keratins. J Biol Chem 1997;272:33197-203.
32. van Eyken P, Sciot R, van Damme B, de Wolf-Peeters C, Desmet VJ. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile duct and acinar gradient. Virchows Arch A Pathol Anat Histopathol 1987;412:63-72.
33. Mitaka T. The current status of primary hepatocyte culture. Int J Exp Pathol 1998;79:393-409.